LexisNexis® Legal Newsroom
Sunstein Kann Murphy and Timbers: Supreme Court Stands to Reshape Patent Law for the Life Sciences

By Nancy Wilker, Ph.D . A member of the Life Sciences Practice Group Two thousand thirteen may end up being the year of life sciences patent law at the Supreme Court. In the last three months, the court has agreed to hear three biotech/pharma cases, the outcomes of which will have sweeping implications...

Reverse Payments by Drug Companies: The Supreme Court Declines to Adopt a Bright-Line Test

by Thomas Carey and Nancy Chiu Wilker Ph.D. Excerpt: The Federal Trade Commission has long opposed "reverse payments," the practice by which a pioneer drug company selling a brand-name drug pays a generic drug company to not enter the market. These payments arise in connection with the...